Shattuck Labs Inc. (STTK) Financial Statements (2024 and earlier)

Company Profile

Business Address 500 W. 5TH STREET
AUSTIN, TX 78701
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:161,300268,800335,400
Cash and cash equivalents47,37992,268157,898
Short-term investments113,901176,536177,551
Other undisclosed cash, cash equivalents, and short-term investments20(4)(49)
Other undisclosed current assets23,28419,46610,239
Total current assets:184,584288,266345,639
Noncurrent Assets
Property, plant and equipment17,6719,9383,000
Other noncurrent assets3,069381349
Total noncurrent assets:20,74010,3193,349
TOTAL ASSETS:205,324298,585348,988
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,30914,3333,724
Employee-related liabilities3,3201,551
Accounts payable7,17010,0121,754
Accrued liabilities5,1391,001419
Deferred revenue   7,728
Estimated litigation liability 1,400  
Other undisclosed current liabilities11,25610,2535,382
Total current liabilities:24,96524,58616,834
Noncurrent Liabilities
Liabilities, other than long-term debt4,2022,21322,293
Deferred revenue   21,306
Deferred rent credit  2,213987
Operating lease, liability4,202  
Total noncurrent liabilities:4,2022,21322,293
Total liabilities:29,16726,79939,127
Equity
Equity, attributable to parent176,157271,786309,861
Common stock555
Additional paid in capital396,041389,408382,012
Accumulated other comprehensive income (loss)(877)(560)(63)
Accumulated deficit(219,012)(117,067)(72,093)
Total equity:176,157271,786309,861
TOTAL LIABILITIES AND EQUITY:205,324298,585348,988

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues65230,0179,934
Gross profit:65230,0179,934
Operating expenses(103,981)(75,286)(46,865)
Operating loss:(103,329)(45,269)(36,931)
Nonoperating income1,384295328
Investment income, nonoperating1,592625549
Other nonoperating expense(208)(330)(221)
Loss from continuing operations:(101,945)(44,974)(36,603)
Loss before gain (loss) on sale of properties:(44,974)(36,603)
Net loss available to common stockholders, diluted:(101,945)(44,974)(36,603)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(101,945)(44,974)(36,603)
Comprehensive loss:(101,945)(44,974)(36,603)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(317)(497)(117)
Comprehensive loss, net of tax, attributable to parent:(102,262)(45,471)(36,720)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: